title: How insurers can bear the burden of proof for new treatments.
authors.affiliation: Independence Blue Cross, USA.
authors.forename: Pierantonio
authors.initials: P
authors.lastname: Russo
authors.forename: Alan
authors.initials: A
authors.lastname: Adler
mesh_terms: D006801:Humans; D008329:Managed Care Programs; D013673:Technology Assessment, Biomedical; D035703:Therapies, Investigational; D014481:United States